Vantage Health

CIK:0001497130|SEC Filings

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Statements of Operations (Unaudited) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Operating expenses
Professional fees	$ 39,433	$ 43,555
General and administrative expenses	32,984	102,253
Officer and director compensation	14,000	36,097
Consulting	6,118	280,375
Total operating expenses	925,359	462,280
Loss from operations	(92,535)	(462,280)
Other income (expense)
Interest income (expense)	(177,075)	(557,647)
Gain (loss) on derivative	(188,030)	1,427,189
Total other income (expense)	(366,105)	869,542
Net (loss) Income	$ (458,640)	$ 407,262
Net income per common share: basic and diluted
Weighted average common shares outstanding: Basic	512,825,081	206,890,967
Weighted average common shares outstanding: Diluted	900,000,000	450,000,000

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
Cash Flows from Operating Activities
Net income (loss)	$ (458,640)	$ 407,262
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount		523,994
Gain loss on derivative liability	188,030	(1,427,189)
Depreciation	8,936	436
Changes in assets and liabilities
Prepaid expense	1,368	35,904
Accounts payable and accrued expenses	60,127	(48,705)
Net cash used in operating activities	(200,179)	(508,298)
Cash Flows from Investing Activities
Purchase of fixed assets
Net cash used in investing activities
Cash Flows from Financing Activities
Proceeds from related party debt	102,164	280,952
Payments on related party debt		(292,611)
Proceeds and penalties from convertible notes payable	133,500	328,010
Proceeds on loans payable		28,501
Payments on loans payable	(35,000)	(26,450)
Net cash from financing activities	200,664	318,402
Net increase (decrease) in cash	485	(189,896)
Cash, beginning of period	60,090	249,986
Cash, end of period	485	60,090
Supplemental disclosure of cash flow information
Cash paid for interest	5,000	49,125
Cash paid for tax
Non-Cash investing and financing transactions
Common stock issued to settle convertible debt	285,494	191,719
Recognition of derivative debt discount		471,288
Conversion of derivative liability		367,970
Exchange of common shares to preferred shares		$ 116,617

Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Current assets
Cash and cash equivalents	$ 485	$ 60,090
Prepaid expenses and other current assets		33,108
Total current assets	485	93,198
Fixed Assets		10,234
Securities-available for sale		400
Total assets	405	103,832
Current liabilities
Accounts payable and accrued liabilities	632,170	289,972
Convertible notes payable	1,562,296	740,720
Due to related parties	1,268,583	396,706
Derivative liabilities	3,140,541	1,170,366
Total current liabilities	6,603,589	2,597,764
Total liabilities	6,603,589	2,597,764
Stockholders' deficit
Preferred stock; $0.001 par value; 50,000,000 shares authorized; 23,473,368 shares issued and outstanding as of September 30, 2016 and June 30, 2016, respectively	23,473	23,473
Common stock; $0.001 par value; 900,000,000 shares authorized; 512,825,018 shares issued and outstanding as of September 30, 2016 and 227,331,108 as of June 30, 2016, respectively	227,331	184,112
Additional paid-in capital	5,177,689	3,865,887
Accumulated deficit	(12,031,597)	(6,567,404)
Total stockholders' deficit	(6,603,104)	(2,493,932)
Total liabilities and stockholders' deficit	$ 485	$ 103,832